Anavex Life Sciences (AVXL) Share-based Compensation (2010 - 2026)
Anavex Life Sciences (AVXL) recorded Share-based Compensation of -$17.08 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with $4.32 million a year earlier.
Powered by 
Analysis
Anavex Life Sciences (AVXL) Share-based Compensation (2010 - 2026) Analysis & Trends
On a TTM basis, Anavex Life Sciences' Share-based Compensation came in at -$11.94 million as of Jun 30, 2026; for FY2025 (ended Sep 30, 2025), it was $11.55 million, up 22.4% from FY2024.
- Annual Share-based Compensation has a five-year compound annual growth rate of 18.8% (FY2020 to FY2025).
- Across earlier fiscal years, Share-based Compensation came in at $9.44 million in FY2024 (-42.3%), $16.37 million in FY2023 (-10.9%), $18.38 million in FY2022 (+123.3%) and $8.23 million in FY2021 (+68.8%).
- The fiscal Q3 2026 figure is the lowest quarterly Share-based Compensation in data going back to fiscal Q4 2010.
- On a year-over-year basis, Share-based Compensation rose in two of the last seven quarters, with an average decline of 8.3%.
- Peak year-over-year performance for Share-based Compensation in the last five years was growth of 377.1% in fiscal Q4 2021, against a decline of 78.3% in fiscal Q2 2026 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $314,000 (Q2 2026), $1.11 million (Q1 2026) and $3.72 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | - |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Anavex Life Sciences | 218.76 Mn | -261.31 Mn | - | -17.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -17.08 Mn |
| Mar 31, 2026 | 314,000.00 |
| Dec 31, 2025 | 1.11 Mn |
| Sep 30, 2025 | 3.72 Mn |
| Jun 30, 2025 | 4.32 Mn |
| Mar 31, 2025 | 1.45 Mn |
| Dec 31, 2024 | 2.06 Mn |
| Sep 30, 2024 | 2.01 Mn |
| Jun 30, 2024 | 2.49 Mn |
| Mar 31, 2024 | 2.65 Mn |
| Dec 31, 2023 | 2.29 Mn |
| Sep 30, 2023 | 3.19 Mn |
| Jun 30, 2023 | 3.87 Mn |
| Mar 31, 2023 | 3.97 Mn |
| Dec 31, 2022 | 5.35 Mn |
| Sep 30, 2022 | 6.04 Mn |
| Jun 30, 2022 | 3.99 Mn |
| Mar 31, 2022 | 4.44 Mn |
| Dec 31, 2021 | 3.91 Mn |
| Sep 30, 2021 | 3.15 Mn |
API Access
Anavex Life Sciences Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=AVXL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "AVXL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=AVXL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();